Alzheimers therapeutics (CeNeS)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameAlzheimers therapeutics (CeNeS)
Drug Alias Namebeta amyloid peptides (CeNeS/St Georges Hospital Medical School)antioxidants (CeNeS/Kings College London)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitorsFree radicals scavengers
TargetsBeta amyloid A4 proteinFree radicals
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCeNeS Pharmaceuticals plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCeNeS Pharmaceuticals plcKing'S College London
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A